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     BSTRACT
In light of improving breeding advice, the frequency was estimated for all the disease-causing 
mutations that were known at the start of the study and that are potentially relevant for a group 
of dog breeds, which are relatively popular or in which the genetic diversity in Belgium is low 
to moderately low. In this study, the results for the German shepherd dog, Malinois, Lakenois, 
Groenendael, Tervuren, Australian shepherd and Border collie are presented. Disorders with a 
frequency high enough to warrant routine genotyping for breeding programs are (1) multidrug 
resistance 1 and hereditary cataract for the Australian shepherd, (2) degenerative myelopathy 
for the German shepherd dog, Malinois and Groenendael and (3) collie eye anomaly for the 
Border collie. In addition, the hyperuricosuria mutation described in the German shepherd dog 
was not found in its Belgian population, but was, to the authors’ knowledge discovered for the 
first time in the Malinois.
SAMENVATTING
Om gerichter fokadvies te kunnen geven, werd de frequentie geschat van alle ziekteveroorzakende 
mutaties die bekend waren bij de start van de studie en potentieel relevant zijn voor een aantal hondenrassen 
die relatief populair zijn of waarvan de genetische diversiteit in België laag tot middelmatig laag is. De 
resultaten voor de Duitse herder, Mechelse herder, Lakense herder, groenendaeler, Tervurense herder, 
Australische herder en bordercollie worden hier besproken. Aandoeningen met een frequentie hoog 
genoeg om deze routinematig te genotyperen voor fokprogramma’s zijn (1) “multidrug resistance 1” 
en “hereditary cataract” voor de Australische herder, (2) degeneratieve myelopathie voor de Duitse 
herder, de Mechelse herder en de groenendaeler en (3) “collie eye anomaly” voor de bordercollie. De 
hyperuricosurie-mutatie, beschreven bij de Duitse herder, werd in deze studie niet aangetroffen bij dit 
ras, maar werd volgens de auteurs wel voor het eerst vastgesteld bij de Mechelse herder.
A
INTRODUCTION
Common breeding practices in domestic dogs, 
combined with a small genetic basis in some breeds 
(Akita inu, Rough collie, Bichon frise, Laekenois, Pa-
pillon) have put the genetic diversity of some breeds 
under pressure. Examples of such practices are selec-
tion purely based on breed standards and the (over)
use of a popular sire (matador breeding) (Calboli et 
al., 2008). Without any doubt, this has an impact on 
the frequency of disease-causing mutations in these 
breeds. Some breeds, such as the Berger des Pyrénées 
and the Braque Saint-Germain, have such a small and/
or decreasing population size that they are considered 
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as endangered (Leroy et al., 2006). In order to im-
prove the genetic health of the breeds involved and 
to avoid the creation of clinically affected individu-
als as much as possible, breeding programs should be 
drafted in such a way that the genetic load imposed 
by hereditary disorders is reduced without reducing 
the genetic diversity even further. Ideally, these pro-
grams could even enhance the genetic diversity at the 
same time. In order to do so, a good knowledge of 
the typical disorders in a particular breed and of the 
frequency of the disease-causing variants is necessary 
(McGreevy and Nicholas, 1999).
Clinical (phenotypical) typing can only be used 
to estimate prevalences of genetic disorders, not fre-
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quencies of causal mutations (Flint and Woolliams, 
2008). It may result in an underestimation of frequen-
cies due to (1) the fact that asymptomatic carriers of 
recessive disorders will not be identified and may 
silently accumulate in populations to a considerable 
degree before popping up in clinical cases, (2) the 
fact that some hereditary disorders are late-onset dis-
eases (Awano et al., 2009; Zangerl et al., 2006), so 
that symptoms often show up after phenotyping and 
after the animal has already produced offspring (Flint 
and Woolliams, 2008), (3) a sometimes broad range in 
severity of the symptoms and (4) possible confusion 
with other diseases. Since the goal of this study was 
to estimate the frequency of causal mutations and give 
breeding advice accordingly, genotyping by using a 
DNA test was the chosen tool. 
The most important limitations of the genotyp-
ing technique are that the causative mutation(s) of 
a disorder is not yet known or that a closely linked 
marker that can be reliably used in marker assisted 
selection, is absent. This is especially true for poly-
genic/multifactorial disorders, several of which are 
sadly enough common in a wide range of dog breeds 
(Online Mendelian Inheritance in Animal (OMIA)). 
As a consequence, nearly all DNA tests available to 
date are for monogenic traits. An example of a poly-
genic disorder, for which there is a DNA test, is the 
one for HD, which only explains a small percentage 
of the variation (Friedenberg et al., 2011). However, 
it should be noted that some disorders can be caused 
independently by several mutations and that a DNA 
test may only detect one of them (Mellersh et al., 
2009). This genetic heterogeneity of a disorder can be 
either caused by different mutations in the same gene 
(allelic heterogeneity) or by mutations in different 
genes (locus heterogeneity) (Gelehrter et al., 1998). 
This means that an animal may be genotyped homo-
zygous wildtype (Wt/Wt) in a certain DNA test and 
still develop the disorder due to another (unknown) 
mutation. 
Due to the lack of specific mutant allele frequen-
cies of the population at hand, extrapolations from 
studies in other populations are frequent. Although 
useful, it may occasionally lead to serious deviation 
from the actual situation. Allele frequencies are sub-
ject to time- and space-related fluctuations caused by 
several factors, of which the popular sire effect is an 
important one in dog breeding (Mellersh, 2008; Le-
roy, 2011). Information from related breeds is some-
times used out of necessity or convenience. This prac-
tice is even more prone to error due to a larger genetic 
divergence and due to the fact that the relationship 
between breeds is not always clear. Extrapolation may 
however be an asset in case of data-poor breeds. For 
example, in this study, DNA tests developed for the 
popular German shepherd dog were used on Malinois, 
Laekenois, Groenendael and Tervuren, often collec-
tively called Belgian shepherds. With the exception 
of the Malinois, the populations of these local breeds 
are small, and only very few genetic studies of these 
breeds have been reported.
In the present study, DNA tests were performed in 
17 dog breeds. In this first part, the results obtained 
for seven shepherd breeds (Australian shepherd, Ger-
man shepherd dog, Groenendael, Laekenois, Mali-
nois, Tervuren and Border collie) are discussed.  The 
results of another ten dog breeds will be discussed in 
part two.
MATERIALS AND METHODS
Breed selection
The breeds included in this study were part of a 
larger group of breeds, of which the genetic diversity 
was studied in the framework of an action program 
of the Flemish Government (Wijnrocx et al., 2012). 
In this program, 23 breeds were studied. Of these, the 
more popular breeds and breeds with the lowest ge-
netic diversity, for which at least two DNA tests were 
available at the start of the study, were chosen for in-
clusion in this frequency study.
Samples and DNA extraction
The blood samples used, originated from a pool of 
samples (stored at -20 °C) delivered by veterinarians, 
animal clinics, breeders and breeder associations from 
all over Belgium for routine genotyping. In order to 
keep the bias at its lowest, closely related animals (re-
lation >12.5%) were excluded. However, this was not 
always possible due to the lack of data or to small 
population size. The aim was to gather at least fifty 
samples (hundred alleles) for each breed. However, 
this number was not reached for the Australian shep-
herd (n = 32) and the Laekenois (n = 27).
For DNA-extraction, whole blood samples collect-
ed in EDTA-tubes, were used. One hundred µl of each 
sample were washed with 500 µl Tris-HCl-EDTA un-
til a clean pellet of white blood cells remained. The 
cells were resuspended in a lysis buffer containing 
proteinase K and DNA was released during a forty-
five-minute incubation step at 56 °C. The enzyme was 
afterwards inactivated during a ten-minute incubation 
step at 95 °C.
Disorders and DNA tests
The disorders were selected based on the data 
found in the literature for each breed. In total, 14 dif-
ferent tests were performed and the mutant and wild-
type allele frequencies were calculated for each dis-
order. Based on these results, it was checked whether 
the populations of the present study deviated from the 
Hardy-Weinberg equilibrium.
All assays were first validated by sequencing 
(golden standard) and later performed with easier, 
quicker and/or cheaper techniques such as PCR 
(-RFLP) followed by gel electrophoresis or qPCR 
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Table 1. Overview of the performed DNA tests. Ta indicates the annealing temperature and F and R indicate forward and 
reverse primers respectively. TR indicates Texas Red.
Disorder: Colly eye anomaly (CEA)   OMIA ID: 000218-9615
Gene symbol: NHEJ1 Inheritance: Autosomal recessive dbvar ID: nsv1397887 Reference: Parker et al., 2007
Assay: PCR with F/R1/R2 primers and gel electrophoresis Ta: 64°C Amplicon: Wt: 322 bp; Mt: 200 bp
Primers: F: 5’-tttggttgcccagtcgatca-3’; R1: 5’-cccctgtttgccgtttaatagatgt-3’; R2: 5’-ccaatcatccagcccagcat-3’   
Disorder: Cyclic neutropenia (CN)   OMIA ID: 000248-9615
Gene symbol: AP3B1 Inheritance: Autosomal recessive dbSNP ID: ss1961068737 Reference: Benson et al., 2003
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 58°C Amplicon: 266 bp
Primers: F: 5’-tttcttggaaggctaagtgg-3’; R: 5’-gaaggtccatgctctctcttac-3’   
Disorder: Degenerative myelopathy (DM)   OMIA ID: 000263-9615
Gene symbol: SOD1 Inheritance: Autosomal recessive dbSNP ID: ss1961068758 Reference: Awano et al., 2009
Assay: qPCR with dual labeled probes  Ta: 56°C Amplicon: 192 bp
Primers: F: 5’-cttccactttcttgtgattg -3’; R: 5’-caccttgtgtattatctccaa-3’ Probes: Wt: HEX-cgccttcagtcagcc-BHQ1;
                 Mt: TR-cgcctttagtcagccc-BHQ2 
Disorder: Hereditary cataract (HC)   OMIA ID: 001758-9615
Gene symbol: HSF4 Inheritance: Autosomal dominant dbSNP ID: ss1961068742 Reference: Mellersh et al., 2006
Assay: PCR with F/R1 primers and sequence analysis with R2 primer Ta: 58°C Amplicon: 218 bp
Primers: F: 5’-tggccccaaacgagtgtgat-3’; R1: 5’-ttagtggtggtctatctgcaaaagtgg-3’; R2: 5’-aggctgttgggcattcctg-3’   
Disorder: Hyperuricosuria (HUU)   OMIA ID: 001033-9615
Gene symbol: SLC2A9 Inheritance: Autosomal recessive dbSNP ID: ss1961068738 Reference: Bannasch et al., 2008
Assay: qPCR with dual labeled probes  Ta: 63°C Amplicon: 101 bp
Primers: F: 5’-ccaaggagatccgtggc-3’; R1: 5’-cttccccagcagctcag-3’ Probes: Wt: FAM-ccatcttcatctgcatcggtgt-BHQ1;
                               Mt: TR-catcttcatcttcatcggtgtgttc-BHQ2 
Disorder: Imerslund-Gräsbeck syndrome (IGS-AS)  OMIA ID: 000565-9615
Gene symbol: AMN Inheritance: Autosomal recessive dbSNP ID: ss1961068745 Reference: He et al., 2005
Assay: PCR with F/R primers and sequence analysis with R primer Ta: 64°C Amplicon: 376 bp
Primers: F: 5'-ggcttggaaggaaggccccca-3'; R: 5'-caaggcggggagcctccgaa-3'   
Disorder: Imerslund-Gräsbeck syndrome (IGS-B)  OMIA ID: 001786-9615
Gene symbol: CUBN Inheritance: Autosomal recessive dbSNP ID: ss1961068736 Reference: Owczarek-Lipska et al., 2013
Assay: PCR with F/R primers and sequence analysis with F-Primer Ta: 62°C Amplicon: 248 bp
Primers: F: 5’-gacttcaaaccccaggacaatc-3’; R: 5’-acatgaatggtgagggtaaacg-3’   
Disorder: Multidrug resistance 1 (MDR1)   OMIA ID: 001402-9615
Gene symbol: ABCB1 Inheritance: Autosomal partially dominant dbSNP ID: ss1961068749 Reference: Mealey et al., 2001
Assay: qPCR with dual labeled probes  Ta: 56°C Amplicon: 180 bp
Primers: F: 5’- gataggttgtatatgttggtg -3’; R: 5’-ctaagatcagtgccacaa-3’ Probes: Wt: HEX-tgcaaagctatctgtcatgtttc-BHQ1;
                              Mt: TR-ttgcaaagctgtcatgtttcc-BHQ2 
Disorder: Mucopolysaccharidosis VII (MPS VII)  OMIA ID: 000667-9615
Gene symbol: GUSB Inheritance: Autosomal recessive dbSNP ID: ss1961068744 Reference: Ray et al., 1998
Assay: qPCR with dual labeled probes  Ta: 62°C Amplicon: 115 bp
Primers: F: 5’-cagcaagttggtccagagc-3’; R: 5’-agacgatggtccctggc-3’ Probes: Wt: FAM-tgtcctcctgccgtattaccct-BHQ1;
                               Mt: TR-tgtcctcctgccatattaccct-BHQ2 
Disorder: Neuronal ceroid lipofuscinosis 5 (NCL5)  OMIA ID: 001482-9615
Gene symbol: CLN5 Inheritance: Autosomal recessive dbSNP ID: ss1961068753 Reference: Melville et al., 2005
Assay: PCR with F/R primers and sequence analysis with R primer Ta: 60°C Amplicon: 214 bp
Primers: F: 5’-aaagcgggacaatgaaacag-3’; R: 5’-tcccaagtaggtaggttctcca-3’   
Disorder: Neuronal ceroid lipofuscinosis 6 (NCL6)  OMIA ID: 001443-9615
Gene symbol: CLN6 Inheritance: Autosomal recessive dbSNP ID: ss1961068755 Reference: Katz et al., 2011
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 64°C Amplicon: 189 bp
Primers: F: 5’-tgcaccagaagcggaagc-3’; R: 5’-tgctgacgtggagggtgtaga-3’   
Disorder: Primary Lens Luxation (PLL)   OMIA ID: 000588-9615
Gene symbol: ADAMTS17 Inheritance: Ausotomal recessive dbSNP ID: ss1961068740 Reference: Farias et al., 2010
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 58°C Amplicon: 169 bp
Primers: F: 5’-gtctccctcacaagcta-3’ ; R: 5’-ggcatatggatagctgtatc-3’   
Disorder: Renal cystadenocarnicoma and nodular dermatofibrosis (RCND)  OMIA ID: 001335-9615
Gene symbol: FLCN Inheritance: Autosomal dominant dbSNP ID: ss1961068743 Reference: Lingaas et al., 2003
Assay: qPCR with dual labeled probes  Ta: 60°C Amplicon: 111 bp
Primers: F: 5’-ctgacctccttgacaag-3’; R: 5’-ccagtataccatgtctactc-3’ Probes: Wt: FAM-catgccttcatacctccttt-BHQ1;
                 Mt: TR-atgccttcgtacctcctt-BHQ2 
Disorder: X-Linked hypohidrotic ectodermal dysplasia (XHED)  OMIA ID: 000543-9615
Gene symbol: EDA Inheritance: X-Linked recessive dbSNP ID: ss1961068763 Reference: Casal et al., 2005
Assay: PCR-RFLP with ScrFI  Ta: 64°C Amplicon: 194 bp
Primers: F: 5’-tcccttcttgttgcctctcacc-3’; R: 5’-ccatcttcaccgcaatcttctg-3’ Fragment Lengths: Wt: 146/25/23 bp; Mt: 169/25 bp
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with dual labeled probes when applicable. All specif-
ics, as well as the performed (alternative) test for each 
disorder can be found in Table 1.
PCR-sequencing
All assays were first validated through PCR fol-
lowed by sequencing. For the PCR, a mix containing 
2.0 µl of the DNA, 5.7 µl sterile, enzyme-free water 
(MQ; Thermo Fisher Scientific Inc., Erembodegem, 
Belgium), 1.0 µl 10x FastStart buffer (Roche Diag-
nostics, Vilvoorde, Belgium), 1.0 µl primers (5 µM 
each, Integrated DNA Technologies, Leuven), 0.2 µl 
deoxynucleoside triphosphate mixture (dNTP’s; 10 
mM each, Gentaur, Kampenhout, Belgium) and 0.1 
µl FastStart polymerase (5 U/µl, Roche Diagnos-
tics, Vilvoorde, Belgium) was made. Hereafter, the 
remaining 8.0 µl PCR product was cleaned up with 
0.6 µl Exo-AP solution (10 µl 20 U/µl exonuclease 
I and 20 µl 5 U/µl antarctic phosphatase in a 30 µl 
stock; Bioké, Leiden, the Netherlands), digesting the 
remaining primers and nucleotides (30' at 37°C, 15' at 
80°C, hold at 4°C). This product was used as template 
for the sequencing reaction. To make the sequence 
mix, 5x sequence buffer (Life Technologies, Ghent, 
Belgium), ReadyReaction mix (RR-mix, Life Tech-
nologies, Ghent, Belgium), primer (2 µM, Integrated 
DNA Technologies, Leuven, Belgium), MQ and GC-
solution (Roche Diagnostics, Vilvoorde, Belgium) 
was added to the template product. After this, the mix 
was sent to Eurofins Scientific (Germany) for running 
the electrophoresis. 
PCR-gel electrophoresis 
The detection of INDELs (insertions and/or dele-
tions) longer than 20 bp was performed by PCR fol-
lowed by gel electrophoresis (PCR-GE). The same 
PCR mix was used as described for PCR-sequencing. 
After the PCR, the mix was loaded on a 2%-agarose 
gel. The length of the fragments is viewed in Table 1.
PCR-RFLP
For mutations creating or abolishing a restriction 
enzyme recognition site, a PCR- restriction frag-
ment length polymorphism (PCR-RFLP) assay was 
performed. The PCR reaction was performed as de-
scribed above, followed by a restriction digest with 
the respective enzyme cutting one of both Wt/Mt al-
leles. This was done overnight with 5 U of enzyme 
according to the instructions of Bioké (Leiden, the 
Netherlands). The end product was loaded on a 3% 
agarose gel to separate the different fragment lengths 
(Table 1).
qPCR with dual labeled probes
The standard mix for the real-time PCR consists 
of 4.7 μl MQ, 1.0 μl 10x FastStart buffer, 1.0 μl 
primers (5 µM each), 0.5 µl of each probe (10 µM, 
Integrated DNA Technologies, Leuven, Belgium), 0.2 
µl dNTP’s (10 mM each), 0.1 µl FastStart Polymerase 
(5 U/µl) and 2.0 µl DNA. The mix was run through a 
PCR program with conditions specific to the disorder 
(Table 1), during which a curve was drafted by the 
Bio-Rad CFX96 C100 TouchTM Thermal Cycler real-
time PCR.
RESULTS AND DISCUSSION
All genotyped disorders for each breed, as well 
as the mutations, for which routine genotyping is ad-
vised, are shown in Table 2. Details on causal muta-
tions and genes can be found in Table 1. An overview 
of all disorders, for which at least one mutant allele 
was found, can be viewed in Table 3. No deviation in 
the Hardy-Weinberg equilibrium was found for any of 
the disorders in the genotyped breeds.
A personal advice is drafted concerning the use of 
DNA-tests. Routine genotyping in breeding dogs is 
not recommended when the mutation was not found 
in the present samples or when the mutant allele fre-
quency is (very) low. However, it might be advisable 
for breeders to test for a condition anyway, e.g. when 
a precedent is known in the family or line or when 
an animal has been imported from another population 
(country), even if the mutant allele frequency is low. 
Genotyping may assist in making a deliberate partner 
choice, thus preventing the birth of affected animals 
and over time reducing the mutant allele frequency. 
By seeking individual genetic counseling, a (further) 
decrease in the genetic diversity can be prevented.
Australian shepherd
Six different tests were performed on the samples 
of the Australian shepherd. Imerslund-Gräsbeck syn-
drome in the Australian shepherd (IGS-AS), an auto-
somal recessive disorder causing cobalamine mal-
absorption, was previously described in a family of 
Australian shepherds in the USA (He et al., 2005), and 
neuronal ceroid lipofuscinosis 6 (NCL6), a neurode-
generative autosomal recessive disorder, was found in 
the USA (O’Brien and Katz, 2008) and the UK (Bond 
et al., 2013). The mutant allele was not found in the 
sample of the present study (n = 31 for IGS-AS and 
n = 32 for NCL6) (Table 2). Given the small sample 
size of this study, the results should be interpreted 
with care, although it can be concluded that the fre-
quency of IGS-AS and NCL6 might be (very) low in 
the Belgian population. No frequency data is avail-
able for other populations. 
Collie eye anomaly (CEA) is a mild autosomal 
recessive disorder of the eye, present in a variety of 
breeds. It is caused by a disruption in the development 
of the retina, chorion and sclera (Parker et al., 2007). 
Two carriers for CEA were detected for the Australian 
shepherd (n = 32) (Table 3), while a higher frequency 
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was estimated for the Border collie (see below). In 
Switzerland, in a clinical retrospective study, a very 
low prevalence of affected Australian shepherds (only 
one affected dog was found out of the 571 samples) 
was found, while a higher percentage of 0.7% was 
found in the Border collie (Walser-Reinhardt et al., 
2009). The results of the present study are in line with 
these findings.
Another defect of the eye is hereditary cataract 
(HC), characterized by blurring of the lens. This is an 
early-onset cataract and probably has an autosomal 
dominant mode of inheritance (Mellersh et al., 2006). 
It should be noted that other forms of cataract are pres-
ent in the Australian shepherd (Mellersh et al., 2009), 
and recently, a new locus associated with cataract in 
this breed has been found (Ricketts et al., 2015). In 
this study, a mutant allele frequency of 7.8% was cal-
culated (n = 32) (Table 3). The fairly high frequency 
of an early-onset dominant disorder may be explained 
by the fact that it is a mild disease, and breeders do 
not specifically select against it. No frequency data 
is available in other countries. Given the fairly high 
frequency, it should be advised to test breeding dogs 
routinely.
Hyperuricosuria (HUU) or urolithiasis is an auto-
somal recessive disorder. In the Dalmatian, all indi-
viduals are homozygous mutant (Bannasch et al., 
2008) and the causal mutation has also been found 
in ten other breeds, including the Australian shepherd 
(Karmi et al., 2010). In this study, two heterozygous 
individuals were found in the 32 tested Australian 
shepherds, leading to a mutant allele frequency of 
3.1% (Table 3). A similar frequency of 3.5% has been 
estimated in the USA (Karmi et al., 2010).
Animals homozygous for the multidrug resistance 1 
(MDR1) mutation  show a high sensitivity to iver-
mectin and several other chemicals due to a lack of 
P-glycoproteins in the blood-brain barrier (Ta ble 1). 
The animals are quickly overdosed and show 
neurotoxic symptoms. The trait is partially dominant, 
in that heterozygous animals are more sensitive, but 
much less than the homozygous mutant ones (Mealey 
et al., 2001). In the present study, a very high mu-
tant allele frequency (q = 29.7%) was found in the 
Australian shepherd, which stands in contrast to the 
0.5% found in the Border collie (see below). Studies 
performed in populations in Germany (Geyer et al., 
2005; Gramer et al., 2011), the USA (Neff et al., 2004; 
Mealey and Meurs, 2008) and the UK (Tappin et al., 
2012), showed similar frequencies for the Australian 
shepherd between 17.0% and 46.0%. Routine testing 
for this mutation should be encouraged, in the first 
place to support the choice of medication for animals 
and secondly to gradually reduce the frequency of the 
mutant allele. The latter should be performed with 
precaution due to the high frequency, and only to the 
degree that it does not endanger the genetic diversity 
of the breed.
Border collie
Six previously described hereditary disorders were 
tested in the Border collie. Cyclic neutropenia (CN) is 
an autosomal recessive inheriting disorder (Benson et 
Table 2. Breeds and general outcome of the DNA tests. A “+” indicates at least one mutant allele was found in the breed. 
A “-” indicates the mutation was not found in the breed. Disorders that should be routinely tested are indicated with 
a “*”.
Breed Outcome Tests
Australian shepherd + Hereditary cataract* (HC), multidrug resistance 1* (MDR1), collie eye
  anomaly (CEA), hyperuricosuria (HUU)
 - Imerslund-Gräsbeck syndrome (IGS-AS), neuronal ceroid lipofuscinosis
  6 (NCL6)
Border collie + CEA*, IGS-B, MDR1
 - Cyclic neutropenia (CN), NCL5, primary lens luxation (PLL)
German shepherd dog + Degenerative myelopathy* (DM), mucopolysaccharidosis type VII
  (MPS VII)
 - HUU, renal cystadenocarcinoma and nodular dermatofibrosis (RCND),
  X-linked anhidrotic ectodermal dysplasia (XHED)
Groenendael + DM*
 - HUU, MPS VII, RCND, XHED
Laekenois - DM, HUU, MPS VII, RCND, XHED
Malinois + DM*, HUU
 - MPS VII, RCND, XHED
Tervuren - DM, HUU, MPS VII, RCND, XHED
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al., 2003) and has been described in the collie, a breed 
closely related to the Border collie (Lund et al., 1967; 
Reynold et al., 1971; Dale et al., 1972). It is character-
ized by oscillations in the number of neutrophils and 
other blood cells (Benson et al., 2003). This disorder 
in the Border collie was tested in the present study, 
but no mutant allele was found in the studied popula-
tion (n = 95). As of yet, no frequency data is available 
in other countries.
For neuronal ceroid lipofuscinosis 5 (NCL5), an 
autosomal recessive neurodegenerative disease (Mel-
ville et al., 2005), the mutation was not found in the 
Belgian population (n = 95). The frequency of the 
mutant allele was estimated to be 3.5% in Australia. 
The mutation is relatively wide spread in that country, 
because some of its champions that carried the muta-
tion, had frequently been used for breeding purposes 
(Melville et al., 2005). Mizukami et al. (2011) found 
a frequency of 8.1% in Japan. This high frequency is 
probably due to the importation of a few Australian 
champions that carried the mutant allele (founder ef-
fect). Moreover, analysis has suggested that the muta-
tion originated in Australia (Mizukami et al, 2012a). 
The lack of a mutation in the Belgian population can 
probably be explained by the fact that there has been 
no contact between the Belgian and the Australian/
Japanese population. In light of these results, it is 
highly recommended to genotype imported animals.
Primary lens luxation (PLL) is an autosomal re-
cessive eye condition (Farias et al., 2010). The causal 
mutation was first found in the miniature bull terrier, 
Jack Russel terrier and Lancashire heeler and is ad-
ditionally present in 14 other breeds (Gould et al., 
2011). This mutation is not seen in some other breeds 
with PLL, suggesting this condition is genetically 
heterogeneous (Gould et al., 2011). Because this mu-
tation is present in the Lancashire heeler, which is a 
closely related breed to the Border collie (Gould et 
al., 2011; Parker et al., 2007), this test was included 
in this study. However, the mutation was not found 
in the tested population (n = 95). Gould et al. (2011) 
genotyped one Border collie with PLL and found it 
Wt/Wt. These results indicate that PLL in the Border 
collie is caused by a different mutation than the one 
described.
Ninety-five Border collies were genotyped for 
CEA, and one (1.1%) homozygous mutant (Mt/Mt) 
and 15 (15.8%) heterozygous (Wt/Mt) animals and a 
mutant allele frequency of 8.9% were found (Table 
3). A clinical study in Switzerland estimated 0.7% af-
fected Border collies (Walser-Reinhardt et al., 2009), 
which is in line with the 1.1% homozygous mutant 
dogs of the present study. As it concerned a clinical 
study, heterozygotes could not be identified. In previ-
ous studies, a frequency of 2.0-3.0% in the UK (Bed-
ford, 1982, referred in Lowe et al., 2003) and the USA 
(Lowe et al., 2003) has been reported. Given the rela-
tively high frequency, genotyping in animals used for 
breeding purposes should be encouraged.
The causal mutation of IGS in the Border collie 
(IGS-B) (Owczarek-Lipska et al., 2013) is situated in 
a different gene than the one in the Australian shep-
herd (He et al., 2005). A carrier (Wt/Mt) frequency 
of 4.3% was estimated in the studied population (n = 
94), which is in line with the 6.2% Owczarek-Lipska 
et al. (2013) found in Switzerland.
Multidrug resistance 1 (MDR1) in the Border col-
lie is caused by the same mutation as in the Austra-
lian shepherd. A mutant allele frequency of 0.5% was 
found in the genotyped population (n = 95) (Table 3), 
which is in contrast with the 29.7% found for the Aus-
tralian shepherd (see above). In the USA (Mealey and 
Meurs, 2008) and in Germany (Gramer et al., 2011) a 
mutant allele frequency of more or less 1.0% has been 
reported. In Japan, 0.5% heterozygotes and 0.3% 
homozygous mutants were found (Mizukami et al., 
2012b). 
German shepherd dog
The German shepherd dog was genotyped for five 
different disorders. No mutation was found in the 
sample for HUU (n = 100), renal cystadenocarcinoma 
and nodular dermatofibrosis (RCND) (n = 96) and X-
linked anhidrotic ectodermal dysplasia (XHED) (n = 
98) (Table 2). Hyperuricosuria is present in the Ger-
man shepherd dog in the USA population (Karmi et 
al., 2010), though at a very low rate, i.e. one carrier 
and one affected dog out of 114 animals genotyped. 
Renal cystadenocarcinoma and nodular dermatofibro-
sis, a renal tumor inheriting in an autosomal dominant 
pattern (Lium and Moe, 1985; Moe and Lium, 1997), 
and XHED, an X-chromosome linked recessive trait 
(Casal et al., 1997; Casal et al., 2005) have been de-
scribed previously in the German shepherd dog. So 
far, no frequency determination has been performed 
for the two last mentioned disorders.
Degenerative myelopathy (DM) is a fatal late-
onset neurodegenerative disorder of the spinal cord 
with an incomplete penetrance and is found in many 
different breeds, including the German shepherd dog. 
Symptoms, typically starting with ataxia in the hind 
limbs, only manifest around the age of six to eight 
years (Awano et al., 2009). The results of the present 
study indicate a very high frequency (q = 21.4%) for 
DM in the Belgian population of the German shep-
herd dog (n = 98) (Table 3). The high frequency may 
be explained by the fact that it concerns a late-onset 
disease and in many cases, animals have already been 
used for breeding purposes before the symptoms ap-
pear. A mutant allele frequency of 15.0% was found 
in a population consisting of Belgian, German and 
Dutch dogs (Broeckx et al., 2013), as well as a 17.0% 
frequency in an Italian population (Capucchio et al., 
2014). In a USA population, the frequency was deter-
mined at 37.0% (Zeng et al., 2014). The Orthopedic 
Foundation for Animals (OFA) reported 16.0% homo-
zygous mutant dogs and 31.6% carriers. It should be 
noted though that these tested dogs were presented 
in an animal clinic, probably creating bias. Notwith-
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standing, it does indicate a similar high frequency for 
DM in the German shepherd dog in the USA as seen 
in Europe. It is strongly recommended to routinely 
genotype for this condition in dogs used for breeding 
purposes.
Mucopolysaccharidosis type VII (MPS VII) is an 
autosomal recessive lysosomal storage disease with 
a progressive course, ending in mortality (Ray et al., 
1998). It was first described in a mixed-breed German 
shepherd dog (Haskins et al., 1984). Only one carrier 
of the GUSB mutation was present in the 96 samples of 
the present study (Table 3). Hence, it can be concluded 
that the mutation is present at a low to very low fre-
quency in the Belgian population of the German shep-
herd dog. This conclusion can probably be extended 
to the general population of German shepherd dogs, 
as up till now, only two cases (one in a mixed-breed 
and one in a German shepherd) of MPS VII have been 
reported (Haskins et al., 1984; Silverstein et al., 2004). 
Broeckx et al. (2013) did not find the mutant allele.
Belgian shepherds
The Groenendael (n = 51), Laekenois (n = 27), 
Malinois (n = 74) and Tervuren (n = 56) are often 
collectively called Belgian shepherds. For these four 
breeds, in this study, DNA tests developed for the 
more popular German shepherd dog were used, since 
they fall under the same breed group by the Fédéra-
tion Cynologique Internationale (FCI). Little data is 
available on the Belgian shepherds and no DNA tests 
are available in the public domain that apply specifi-
cally to them. No mutant allele was found in any of 
these breeds for MPS VII, RCND and XHED (Table 
2). A few clinical cases with symptoms resembling 
and strongly indicating XHED have been described 
in the Belgian shepherd (Muller and Kirk, 1976), with 
no further specification of the breed. 
Two DM carriers were identified in the Groenen-
dael population of the present study and a mutant al-
lele frequency of 7.5% was estimated for the Mali-
nois (Table 3). The OFA reported the presence of DM 
in three Belgian shepherd breeds, with a frequency 
of 3.6% for the Malinois (n = 28), 37.5% for the 
Groenendael (n = 8) and 9.1% for the Tervuren (n = 
11). Unlike the findings by the OFA, the mutation was 
not present in the Tervuren population of the pres-
ent study. It should be noted that the used samples of 
the OFA originate from animal clinics only, probably 
leading to an overestimation of frequency. However, 
it can be concluded that the DM mutation is present 
in all three breeds of the USA population. Recently, a 
mutant allele frequency of 6.0% has been calculated 
for a USA population of 101 Malinois (Zeng et al., 
2014). This is a result similar to what was found in 
the Belgian population of the present study. Because 
of the fairly high frequency in the Malinois, which is 
however not quite as high as the one found in the Ger-
man shepherd dog, and because of the severity of the 
disorder, it is strongly recommended to routinely test 
for this disorder in the Malinois and the Groenendael.
Next to the Dalmatian and the Australian shepherd, 
HUU is present in the German shepherd dog (Karmi 
et al., 2010). Therefore, the Belgian shepherds were 
also genotyped for this trait. Three carriers and one 
affected dog were found in the Malinois samples (n 
= 74) (Table 3). The mutation was solely found in the 
Malinois and was absent in the other three shepherd 
breeds.
GENERAL DISCUSSION AND CONCLUSION
For XHED, an X-chromosome linked disorder, a 
mutant allele was neither found in the Belgian nor in 
the German shepherd dog (see also part 2).
Table 3. Overview of the tests with at least one mutant allele detected for each breed with the total number of dogs 
tested (Total), the number of homozygous normal (Wt/Wt), heterozygous (Wt/Mt) and affected (Mt/Mt) individuals 
and the mutant allele frequency (q).
                   Breed Test Total Wt/Wt Wt/Mt Mt/Mt q (%)
Australian shepherd CEA 32 30 2 0 3.1
 HC 32 27 5 0 7.8
 HUU 32 30 2 0 3.1
 MDR1 32 15 15 2 29.7
Border collie CEA 95 79 15 1 8.9
 IGS-B 94 90 4 0 2.1
 MDR1 95 94 1 0 0.5
German shepherd dog DM 98 62 30 6 21.4
 MPS VII 96 95 1 0 0.5
Groenendael DM 51 49 2 0 2.0
Malinois DM 73 63 9 1 7.5
 HUU 74 70 3 1 3.4
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A low mutant allele frequency may be explained 
by the fact that males only carry one X-chromosome. 
Provided that the disease is early-onset and has a 100% 
penetrance, carrying a mutant allele will be pheno-
typically identifiable and the dog will most likely be 
excluded from breeding programs. Since males sire 
more offspring than females, the exclusion of affected 
male dogs will have a great impact on the prevalence 
of these disorders, resulting in a lower frequency.
A similar conclusion can be reached for the auto-
somal dominant trait RCND (in the Belgian shepherds 
and the German shepherd), which is an early-onset 
disorder with a full penetrance of clear symptoms. The 
mutant allele cannot unknowingly be passed on from 
generation to generation. No mutant allele was found 
for this disorder. HC probably has an autosomal domi-
nant mode of inheritance and is an early-onset disease, 
though a mutant allele frequency of 7.8% was found. 
This may be explained by the fact that the disorder is 
relatively mild; hence, there is no or only weak selec-
tion against it. A very high frequency of 29.7% for the 
MDR1 mutation was found in the Australian shepherd. 
While being a partially dominant trait, MDR1 is not 
a disease per se and only becomes clear when the af-
fected dog is given the wrong medication.
For most of the genotyped dogs, no or only one dis-
ease-causing mutation was found. However, several 
dogs carried two or even three of the studied muta-
tions. One Australian shepherd tested heterozygous 
for HC, MDR1 and CEA. The frequencies found in 
this study were generally in line with those described 
for populations elsewhere, but there is one that shows a 
significant deviation, thus proving population specific 
dynamics and the importance of this type of study. For 
DM in the Groenendael (q = 3.9%) and the Tervuren 
(q = 0.0%), a (very) low frequency was found. This 
is in contrast with the high frequencies found by the 
OFA of 37.5% and 9.1% for the Groenendael and the 
Tervuren, respectively. This is a noticeable difference, 
even considering the selection bias by the OFA.
Neuronal ceroid lipofuscinosis 5 in the Border col-
lie is a clear example of the founder and popular sire 
effect (Mizukami et al., 2012a). It might also explain 
why the mutation was not seen in the Belgian popula-
tion of the present study. 
High enough frequencies to warrant routine ge-
notyping in breeding programs were found for DM 
in the German shepherd dog, the Malinois and the 
Groenendael, MDR1 and HC in the Australian shep-
herd and CEA in the Border collie. Genotyping can be 
used to make a deliberate partner choice or sometimes 
to exclude animals from breeding programs. Hetero-
zygotes, and in case of a very high frequency also ho-
mozygote mutants, should not be routinely excluded 
from breeding programs, since this may (further) 
endanger the genetic diversity. They may be paired 
with homozygous normal individuals, thus slowly but 
surely decreasing the mutant allele frequency. Indi-
vidual genetic counseling can be sought after getting 
the genotyping results.
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